Eli Lilly (LLY) Free Cash Flow (2009 - 2026)

Eli Lilly (LLY) has reported Free Cash Flow for 18 consecutive years, with $3.0 billion the latest figure, recorded in Q1 2026.

• Free Cash Flow for Q1 2026 came in at $3.0 billion, up 1827.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.8 billion (up 216.44% YoY), and the FY2025 annual result was $9.0 billion, up 138.62% from the prior year.
• Free Cash Flow was $3.0 billion for Q1 2026 at Eli Lilly, up from $677.9 million in the prior quarter.
• Over five years, Free Cash Flow peaked at $6.7 billion in Q3 2025 and troughed at -$1.4 billion in Q4 2023.
• Average Free Cash Flow over 5 years is $1.3 billion, with a median of $1.1 billion recorded in 2023.
• Year-over-year, Free Cash Flow tumbled 219.02% in 2023 and surged 1827.56% in 2026.
• Over 5 years, Free Cash Flow stood at $1.2 billion in 2022, then sank by 219.02% to -$1.4 billion in 2023, then surged by 170.69% to $977.7 million in 2024, then tumbled by 30.66% to $677.9 million in 2025, then jumped by 343.58% to $3.0 billion in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were $3.0 billion in Q1 2026, $677.9 million in Q4 2025, and $6.7 billion in Q3 2025.